ethyl 2-(3,5-dibromo-1H-1,2,4-triazol-1-yl)acetate, 95.0%, 2g

5-(1,5-dimethyl-1H-pyrazol-3-yl)-1,3,4-oxadiazol-2-amine, 95.0%, 500mg

1-(Tert-butyl)-3-ethylbenzene, 98+%, 5g

2-Cyano-6-methoxybenzothiazole, 98.0%, 250mg

cis-1-N-Boc-4-Methoxy-L-proline, 95.0%, 1g

Fmoc-D-Asp(OAll)-OH, 95.0%, 5g

Yttrium ICP standard solution, ROTI®Star, 10000 mg/l Y, density (D) ~1 g/cm³

Di([1,1':3',1''-terphenyl]-4-yl)amine>95.0%(HPLC)(T)5g

(2S,2'S,3S,3'S)-3,3'-Di-tert-butyl-2,2'-diisopropyl-2,2',3,3'-tetrahydro-4,4'-bibenzo[d][1,3]oxaphosphole, 97% 99%ee, 500mg

(3,4-Difluoro-5-methoxyphenyl)boronic acid, 95.0%, 5g

(1R,2S)-1,2-di(pyridin-4-yl)ethane-1,2-diol, 98%, 250mg

Bismuth Target 99.999% dia. 101.6 x thickness 6.35 mm 1 pc

1,1,2,2-Tetrakis(4-methoxyphenyl)-1,2-ethanediol>96.0%(HPLC)1g